| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 07/13/2004 | US6762300 Method for producing 5-(1-piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination |
| 07/13/2004 | US6762197 Fungicides |
| 07/13/2004 | US6762195 Treating diseases mediated by tumor necrosis factor; inhibit angiogenesis and treatment of cancer, inflammatory, and autoimmune diseases |
| 07/13/2004 | US6762194 Quinolinone derivatives |
| 07/13/2004 | US6762181 Broad antibacterial activity including drug resistant staphylococcus aureus (mrsa), pneumococcus (prsp) and enterococcus (vre); safely used in conjuction with nonsteroidal antiinflammatory drugs |
| 07/13/2004 | US6762180 Substituted indolines which inhibit receptor tyrosine kinases |
| 07/13/2004 | US6762179 (2-arylamino-4-thiazole)pyrimidine compounds; useful for treating diabetes, alzheimer's disease, stroke, proliferative disorders, and asthma |
| 07/13/2004 | US6762178 For use in treatment of disease conditions mediated by tnf-alpha, such as rheumatoid arthritis, osteoarthritis, sepsis, aids, ulcerative colitis, multiple sclerosis, crohn's disease, degenerative cartilage loss |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | CA2313106C Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents |
| 07/13/2004 | CA2272690C Process for making 2-amino-2-imidazoline, guanidine, and 2-amino-3,4,5,6-tetrahydropyrimidine derivatives |
| 07/13/2004 | CA2255333C Quinolinone derivative, method for preparing the same, and anti-allergic agent |
| 07/08/2004 | WO2004056812A1 4- (pyridin-4-ylamino) -quinazoline derivatives as anti-tumor agents |
| 07/08/2004 | WO2004056810A1 Xanthine derivatives as muscarinic receptor antagonists |
| 07/08/2004 | WO2004056807A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 07/08/2004 | WO2004056806A1 2-(1h-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophtalmic diseases |
| 07/08/2004 | WO2004056805A1 Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056800A1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056799A2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056786A2 Pyrimidine derivates for the treatment of abnormal cell growth |
| 07/08/2004 | WO2004056782A1 Pyrazole compounds |
| 07/08/2004 | WO2004056780A2 Tetrahydroquinoline derivatives |
| 07/08/2004 | WO2004056775A1 Microsomal triglyceride transfer protein inhibitors |
| 07/08/2004 | WO2004056774A2 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators |
| 07/08/2004 | WO2004056773A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | WO2004056772A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as tachykinin antagonists |
| 07/08/2004 | WO2004056767A1 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists |
| 07/08/2004 | WO2004056369A1 Benzo ‘ d!azepine derivatives for the treatment of neurological disorders |
| 07/08/2004 | WO2004056365A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 07/08/2004 | WO2004056364A1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004051217A3 Process for synthesis bis-aryl diamidoxime compounds |
| 07/08/2004 | WO2004050018A3 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents |
| 07/08/2004 | WO2004041755A3 Quinazolinone compounds as calcilytics |
| 07/08/2004 | WO2004037171A3 Mitotic kinesin inhibitors |
| 07/08/2004 | WO2004029578A3 Energy transfer dyes, terminators and use thereof |
| 07/08/2004 | WO2004012663A3 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme |
| 07/08/2004 | WO2004009017A3 Modulators of the glucocorticoid receptor and method |
| 07/08/2004 | WO2004000764A3 BENZO(b)FURAN DIMERS |
| 07/08/2004 | WO2003103663A3 Substituted pyrrolines as kinase inhibitors |
| 07/08/2004 | WO2003097593A3 Protease inhibitors |
| 07/08/2004 | US20040133011 Useful for therapy of noninsulin-dependent diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome |
| 07/08/2004 | US20040133008 Amide compounds |
| 07/08/2004 | US20040133007 Process for preparing amine-substituted benzofurans |
| 07/08/2004 | US20040133005 Process for preparing substituted pyridnes |
| 07/08/2004 | US20040132981 modified ligands that bind irreversibly to their cognate receptors; assay for investigating protein function and as drugs for more effectively inhibiting or stimulating cognate receptor function |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132807 Aurones as telomerase inhibitors |
| 07/08/2004 | US20040132801 Therapeutic proline derivatives |
| 07/08/2004 | US20040132800 aminomethyl- or ethyl-substituted indoles, tetrahydrocarbazoles and tetrahydropyrido[1,2-a]indoles |
| 07/08/2004 | US20040132794 Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 07/08/2004 | US20040132788 thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives; treating neurodegenerative disorders or pain. |
| 07/08/2004 | US20040132786 Differential tumor cytotoxicity compounds and compositions |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132779 benzoyl- or pyridinoyl-amimo phenyl- or pyridinylmethylaminocarbonyl compounds, e.g., 4-[(2-acetylamino-2-phenyl-acetylamino)-methyl]-2-methylphenyl-4'-trifluoromethylbiphenyl-2-carboxamide; antiobesity and antiatherosclerosis agents |
| 07/08/2004 | US20040132772 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis |
| 07/08/2004 | US20040132758 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 07/08/2004 | US20040132752 cyclic ureas and triazolones; treatment or prevention of excessive weight or obesity, and for treatment of Type II diabetes, arteriosclerosis, high blood pressure, depression, anxiety, anxiety neuroses, and schizophrenia. |
| 07/08/2004 | US20040132736 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/08/2004 | US20040132733 Novel quinoxalinone derivatives as bradykinin B1 antagonists |
| 07/08/2004 | US20040132732 Quinazolinones and derivatives thereof as factor Xa inhibitors |
| 07/08/2004 | US20040132730 Inhibitors of TGFbeta |
| 07/08/2004 | US20040132727 Quinoline and quinazoline derivatives and drugs containing the same |
| 07/08/2004 | US20040132724 e.g., cis-1-Acetyl-6-ethyl-N-(4-ethylphenyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinamine; atopic dermatitis, urticaria, various allergies bullous pemphigoid, industrial sensitization, chronic transplant rejection and COPD |
| 07/08/2004 | US20040132722 Glycoprotein-mediated MDR |
| 07/08/2004 | US20040132721 Treatment of airway disorders |
| 07/08/2004 | US20040132720 Antidepressants |
| 07/08/2004 | US20040132710 Lactams as tachkinin antagonists |
| 07/08/2004 | US20040132693 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha converting enzyme (TACE) |
| 07/08/2004 | US20040131551 Chelate compounds; magnetic resonance imaging |
| 07/08/2004 | DE10257358A1 Substituierte Pyrrole Substituted pyrroles |
| 07/08/2004 | CA2511726A1 Xanthine derivatives as muscarinic receptor antagonists |
| 07/08/2004 | CA2510850A1 2-(1h-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases |
| 07/08/2004 | CA2510848A1 Pyrimidine derivates for the treatment of abnormal cell growth |
| 07/08/2004 | CA2510815A1 Microsomal triglyceride transfer protein inhibitors |
| 07/08/2004 | CA2510471A1 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators |
| 07/08/2004 | CA2509403A1 Pyrazole compounds |
| 07/08/2004 | CA2508657A1 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | CA2508624A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/07/2004 | EP1435356A1 Quinoline derivatives as CRTH2 antagonists |
| 07/07/2004 | EP1435353A1 Novel heterocyclic compound and anti-inflammatory agent |
| 07/07/2004 | EP1434778A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
| 07/07/2004 | EP1434775A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 07/07/2004 | EP1434773A2 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 07/07/2004 | EP1434765A1 Substituted piperidines with selective binding to histamine h3-receptor |
| 07/07/2004 | EP1434584A2 Compositions and methods of treatment of cancer |
| 07/07/2004 | EP1434579A1 Imidazole derivatives as antiinflammatory agents |
| 07/07/2004 | EP1434577A1 Pyrrolidinone derivatives |
| 07/07/2004 | EP1434485A1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 07/07/2004 | EP1047694B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 07/07/2004 | CN1511192A Production of polyketides |
| 07/07/2004 | CN1511152A N-formyl hydroxylamine compounds as PDF inhibitor |
| 07/07/2004 | CN1511151A 3-quinoline-2-(1H)-ylideneindolin-2-one derivatives |
| 07/07/2004 | CN1511143A Herbicidal substituted benzoylpyrazoles |
| 07/07/2004 | CN1511140A Oxime ether compound and agricultural or horticultural bactericide |
| 07/07/2004 | CN1510035A Preparation of Aomeishatan |
| 07/07/2004 | CN1510034A Indazole compound, preparing method thereof and medicine composition containing the same |
| 07/07/2004 | CN1156472C Benzotrizole derivative as agro-chemical |
| 07/07/2004 | CN1156470C New Substituted pyridyl keto enols |
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/07/2004 | CN1156451C Betz 2-adrenoceptor agonists |